- Home
- IOSP
IOSP
Innospec Inc.
as of 03-13-2026 3:59pm EST
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
| Founded: | 1938 | Country: | United States |
| Employees: | N/A | City: | ENGLEWOOD |
| Market Cap: | 1.9B | IPO Year: | 1998 |
| Target Price: | $124.00 | AVG Volume (30 days): | 200.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | annual | |
| EPS: | 4.67 | EPS Growth: | 228.87 |
| 52 Week Low/High: | $68.67 - $99.63 | Next Earning Date: | 05-21-2026 |
| Revenue: | $1,778,000,000 | Revenue Growth: | -3.65% |
| Revenue Growth (this year): | 5.96% | Revenue Growth (next year): | 6.10% |
| P/E Ratio: | 14.74 | Index: | N/A |
| Free Cash Flow: | 120.7M | FCF Growth: | -38.51% |
AI-Powered IOSP Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Innospec Inc. (IOSP)
SVP, GC & CCO
Avg Cost/Share
$75.64
Shares
1,028
Total Value
$77,757.92
Owned After
14,693
SEC Form 4
EVP & CFO
Avg Cost/Share
$76.56
Shares
2,380
Total Value
$182,212.80
Owned After
20,357
SEC Form 4
Director
Avg Cost/Share
$76.56
Shares
594
Total Value
$45,474.38
Owned After
7,632
SEC Form 4
Director
Avg Cost/Share
$76.56
Shares
119
Total Value
$9,110.19
Owned After
6,508
SEC Form 4
Director
Avg Cost/Share
$76.56
Shares
594
Total Value
$45,474.38
Owned After
9,453
SEC Form 4
Director
Avg Cost/Share
$76.56
Shares
594
Total Value
$45,474.38
Owned After
10,530
SEC Form 4
Director
Avg Cost/Share
$81.84
Shares
1,030
Total Value
$84,296.13
Owned After
9,453
SEC Form 4
Director
Avg Cost/Share
$81.84
Shares
1,030
Total Value
$84,296.13
Owned After
10,530
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Jones David B. | IOSP | SVP, GC & CCO | Mar 3, 2026 | Sell | $75.64 | 1,028 | $77,757.92 | 14,693 | |
| Cleminson Ian | IOSP | EVP & CFO | Feb 27, 2026 | Sell | $76.56 | 2,380 | $182,212.80 | 20,357 | |
| LANDLESS DAVID | IOSP | Director | Feb 27, 2026 | Sell | $76.56 | 594 | $45,474.38 | 7,632 | |
| Poccia Claudia | IOSP | Director | Feb 27, 2026 | Sell | $76.56 | 119 | $9,110.19 | 6,508 | |
| PADFIELD Larry | IOSP | Director | Feb 27, 2026 | Sell | $76.56 | 594 | $45,474.38 | 9,453 | |
| Blackmore Milton C | IOSP | Director | Feb 27, 2026 | Sell | $76.56 | 594 | $45,474.38 | 10,530 | |
| PADFIELD Larry | IOSP | Director | Feb 20, 2026 | Sell | $81.84 | 1,030 | $84,296.13 | 9,453 | |
| Blackmore Milton C | IOSP | Director | Feb 20, 2026 | Sell | $81.84 | 1,030 | $84,296.13 | 10,530 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 18, 2026 · 100% conf.
Q4 2025 Earnings
8-K BUYFeb 18, 2026 · 100% conf.
1D
+2.21%
$88.27
Act: -4.28%
5D
+3.70%
$89.55
Act: -9.51%
20D
+2.18%
$88.24
8-K
false 0001054905 0001054905 2026-02-17 2026-02-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2026
INNOSPEC INC.
(Exact name of registrant as specified in its charter) Commission File Number: 1-13879
Delaware
98-0181725
(State or other jurisdiction of incorporation)
(IRS Employer Identification No.)
8310 South Valley Highway, Suite 350 Englewood, Colorado, 80112 (Address of principal executive offices, including zip code) (303)792-5554 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock
IOSP
NASDAQ
Item 2.02 Results of Operations and Financial Condition. On February 17, 2026, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter and year ended December 31, 2025 (the “Press Release”). Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
EXHIBIT INDEX
Number
Description
Method of Filing
99.1
Press Release dated February 17, 2026 announcing Innospec Inc.’s financial results for the fiscal year ended December 31, 2025.
Filed Herewith
104
Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INNOSPEC INC.
Date: February 18, 2026
By:
/s/ David B. Jones
David B. Jones
Senior Vice President, General Counsel and Chief Compliance Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 5, 2025
Q3 2025 Earnings
8-KNov 5, 2025
8-K
false 0001054905 0001054905 2025-11-04 2025-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2025
INNOSPEC INC.
(Exact name of registrant as specified in its charter) Commission File Number: 1-13879
Delaware
98-0181725
(State or other jurisdiction of
(IRS Employer
incorporation)
Identification No.) 8310 South Valley Highway, Suite 350 Englewood, Colorado, 80112 (Address of principal executive offices, including zip code) (303)792-5554 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [ ] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act [ ] Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock
IOSP
NASDAQ
Item 2.02 Results of Operations and Financial Condition. On November 4, 2025, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025 (the “Press Release”). Item 7.01 Regulation FD Disclosure The Press Release also announced that on November 2, 2025, the Company’s Board of Directors declared a semi-annual dividend of $0.87 per share on the Company’s common stock (IOSP). The dividend will be paid on November 26, 2025, to holders of record on November 18, 2025. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
EXHIBIT INDEX
Number
Description
Method of Filing
99.1
Press Release dated November 4, 2025, announcing Innospec Inc.’s financial results for the fiscal quarter ended September 30, 2025
Filed Herewith
104
Cover Page Interactive Data File – the cover page XBRL tags are embedded
within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INNOSPEC INC.
Date: November 5, 2025
By:
/s/ David B. Jones
David B. Jones
Senior Vice President, General Counsel and Chief Compliance Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 6, 2025
Q2 2025 Earnings
8-KAug 6, 2025
8-K
false 0001054905 0001054905 2025-08-05 2025-08-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025
INNOSPEC INC.
(Exact name of registrant as specified in its charter) Commission File Number: 1-13879
Delaware
98-0181725
(State or other jurisdiction of
(IRS Employer
incorporation)
Identification No.) 8310 South Valley Highway, Suite 350 Englewood, Colorado, 80112 (Address of principal executive offices, including zip code) (303)792-5554 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [ ] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act [ ] Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock
IOSP
NASDAQ
Item 2.02 Results of Operations and Financial Condition. On August 5, 2025, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 30, 2025 (the “Press Release”). Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
EXHIBIT INDEX
Number
Description
Method of Filing
99.1
Press Release dated August 5, 2025 announcing Innospec Inc.’s financial results for the fiscal quarter ended June 30, 2025
Filed Herewith
104
Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INNOSPEC INC.
Date: August 6, 2025
By:
/s/ David B. Jones
David B. Jones
Senior Vice President, General Counsel and Chief Compliance Officer
Compare IOSP vs Leading Stocks
See how IOSP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IOSP Innospec Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.